BK Virus Nephropathy in Kidney Transplantation: An Approach Proposal and Update on Risk Factors, Diagnosis, and Treatment

被引:28
作者
Gonzalez, S. [1 ]
Escobar-Serna, D. P. [1 ]
Suarez, O. [1 ]
Benavides, X. [1 ]
Escobar-Serna, J. F. [2 ]
Lozano, E. [1 ,3 ]
机构
[1] Univ Nacl Colombia, Sch Med, Dept Surg, Organ & Tissues Transplant Grp, Bogota, Colombia
[2] Univ Antioquia, Internal Med & Crit Care, Medellin, Colombia
[3] Hosp Univ San Ignacio, Bogota, Colombia
关键词
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY; RENAL-ALLOGRAFT RECIPIENTS; POLYMERASE-CHAIN-REACTION; ACYCLIC NUCLEOSIDE PHOSPHONATES; LOW-DOSE CIDOFOVIR; LARGE T-ANTIGEN; INTERSTITIAL NEPHRITIS; LOAD MEASUREMENT; IN-VIVO; REPLICATION;
D O I
10.1016/j.transproceed.2015.05.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BK virus belongs to Polyomaviridae family; it causes 95% of nephropathy cases related to polyomavirus, with the other 5% caused by JC virus. Nephropathy jeopardizes graft function, causing a premature failure of the graft in 1%-10% of patients with kidney transplants. Nowadays, antiviral effective treatment is unknown, which is why blood and urine screening of renal transplantation patients has become the most important recommendation to guide the decrease of immunosuppression, and the only proven method to decrease poor outcomes. Different interventions, such as cidofovir, leflunomide, fluoroquinolones, and intravenous immunoglobulin, have been attempted with no improvement at all. This review aims to summarize the most relevant features of BK virus, historical issues, transmission mechanisms, risk factors, and therapeutic interventions.
引用
收藏
页码:1777 / 1785
页数:9
相关论文
共 122 条
[1]  
Ali SH, 2007, ANTIVIR THER, V12, P1
[2]   Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients [J].
Almeras, C. ;
Vetromile, F. ;
Garrigue, V. ;
Szwarc, I. ;
Foulongne, V. ;
Mourad, G. .
TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (02) :101-108
[3]   Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab [J].
Anzivino, Elena ;
Bellizzi, Anna ;
Mitterhofer, Anna Paola ;
Tinti, Francesca ;
Barile, Mario ;
Colosimo, Maria Teresa ;
Fioriti, Daniela ;
Mischitelli, Monica ;
Chiarini, Fernanda ;
Ferretti, Giancarlo ;
Taliani, Gloria ;
Pietropaolo, Valeria .
VIROLOGY JOURNAL, 2011, 8
[4]  
Araya CE, 2008, PEDIATR TRANSPLANT, V12, P790, DOI 10.1111/j.1399-3046.2008.00937.x
[5]   Polyoma virus and simian virus 40 as cancer models: History and perspectives [J].
Atkin, Sarah J. L. ;
Griffin, Beverly E. ;
Dilworth, Stephen M. .
SEMINARS IN CANCER BIOLOGY, 2009, 19 (04) :211-217
[6]   Prospective evaluation of BK virus DNAemia in renal transplant patients and their transplant outcome [J].
Basse, G. ;
Mengelle, C. ;
Kamar, N. ;
Guitard, J. ;
Ribes, D. ;
Esposito, L. ;
Rostaing, L. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (01) :84-87
[7]   Clinicopathotogic analysis of patients with BK viruria and rejection-like graft dysfunction [J].
Batal, Ibrahim ;
Franco, Zachary M. ;
Shapiro, Ron ;
Basu, Amit ;
Tan, Henkie ;
Kayler, Liise ;
Zeevi, Adriana ;
Morgan, Claire ;
Randhawa, Parmjeet .
HUMAN PATHOLOGY, 2009, 40 (09) :1312-1319
[8]   Polyomavirus disease under new immunosuppressive drugs - A cause of renal graft dysfunction and graft loss [J].
Binet, I ;
Nickeleit, V ;
Hirsch, HH ;
Prince, O ;
Dalquen, P ;
Gudat, F ;
Mihatsch, MJ ;
Thiel, G .
TRANSPLANTATION, 1999, 67 (06) :918-922
[9]   Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients [J].
Binggeli, S. ;
Egli, A. ;
Schaub, S. ;
Binet, I. ;
Mayr, M. ;
Steiger, J. ;
Hirsch, H. H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) :1131-1139
[10]   Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA [J].
Bofill-Mas, S ;
Formiga-Cruz, M ;
Clemente-Casares, P ;
Calafell, F ;
Girones, R .
JOURNAL OF VIROLOGY, 2001, 75 (21) :10290-10299